Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

This trial compared the rate and time of viral clearance in subjects receiving a combination of nitazoxanide, ribavirin, and ivermectin plus Zinc versus those receiving supportive treatment. This non‐randomized controlled trial included 62 patients on the triple combination treatment versus 51 age‐...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Med Virol
Glavni autori: Elalfy, Hatem, Besheer, Tarek, El‐Mesery, Ahmed, El‐Gilany, Abdel‐Hady, Soliman, Mahmoud Abdel‐Aziz, Alhawarey, Ahmed, Alegezy, Mohamed, Elhadidy, Tamer, Hewidy, Asem A., Zaghloul, Hossam, Neamatallah, Mustafa Ahmed Mohamed, Raafat, Douaa, El‐Emshaty, Wafaa M., Abo El Kheir, Nermin Y., El‐Bendary, Mahmoud
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014583/
https://ncbi.nlm.nih.gov/pubmed/33590901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26880
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items